We are live on ! Find out more
BBP icon

Virtus Biotech ETF
BBP

16 hedge funds and large institutions have $10.6M invested in Virtus Biotech ETF in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

29% more capital invested

Capital invested by funds: $8.16M → $10.6M (+$2.39M)

7% more funds holding

Funds holding: 15 → 16 (+1)

2.68% more ownership

Funds ownership: 35% → 37.68% (+2.7%)

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$808K
2
Citadel Advisors
Citadel Advisors
Florida
+$513K
3
LPL Financial
LPL Financial
California
+$132K
4
CAMG
CWA Asset Management Group
Florida
+$48.5K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$29.9K

Top Sellers

Rank Fund Capital Flow
1
Raymond James Financial
Raymond James Financial
Florida
-$715K
2
Morgan Stanley
Morgan Stanley
New York
-$52.8K
3
FTUS
Flow Traders U.S.
New York
-$51.7K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$33K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
1
Jane Street
New York
$2.16M +$808K +12,339 +67%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$2.03M +$29.9K +457 +2%
CAMG
3
CWA Asset Management Group
Florida
$1.66M +$48.5K +741 +3%
Citadel Advisors
4
Citadel Advisors
Florida
$1.05M +$513K +7,834 +110%
Morgan Stanley
5
Morgan Stanley
New York
$1.01M -$52.8K -806 -5%
IFG
6
Independent Financial Group
California
$499K +$1.31K +20 +0.3%
FTUS
7
Flow Traders U.S.
New York
$463K -$51.7K -790 -11%
Raymond James Financial
8
Raymond James Financial
Florida
$456K -$715K -10,915 -63%
LPL Financial
9
LPL Financial
California
$436K +$132K +2,015 +48%
Wealth Enhancement Advisory Services
10
Wealth Enhancement Advisory Services
Minnesota
$363K – – –
Cetera Investment Advisers
11
Cetera Investment Advisers
Illinois
$342K +$13.7K +209 +4%
Carson Wealth (CWM LLC)
12
Carson Wealth (CWM LLC)
Nebraska
$50K – – –
Osaic Holdings
13
Osaic Holdings
Arizona
$31.2K – – –
Comerica Bank
14
Comerica Bank
Texas
$7.42K +$6.94K +106 New
AF
15
Allworth Financial
California
$4.97K +$4.65K +71 New
GEA
16
Glen Eagle Advisors
New Jersey
$3.5K – – –
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– -$33K -571 Closed

BBP Hedge Fund Activity: Q3 2025 in Review

16 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q3 2025, worth a combined $10.6M — up 29% from $8.16M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BBP positions and 1 closed out — a net gain of 1 holder — while 7 added to existing stakes and 3 trimmed.

The largest buyer was Jane Street, adding an estimated $808K. The largest seller was Raymond James Financial, cutting an estimated $715K.

  • 16 institutional investors held Virtus Biotech ETF (BBP) as of Q3 2025, up from 15 in Q2 2025.
  • Funds reported $10.6M of Virtus Biotech ETF stock for Q3 2025, up 29% quarter-over-quarter.
  • 2 funds opened new Virtus Biotech ETF positions in Q3 2025 and 1 closed out, a net change of +1 holder.
  • The largest Virtus Biotech ETF buyer in Q3 2025 was Jane Street, an estimated $808K added.
  • The largest Virtus Biotech ETF seller in Q3 2025 was Raymond James Financial, an estimated $715K sold.

Based on aggregated 13F filings for Q3 2025.